Publications

1.

Salary differences between male and female registered nurses in the United States.

Muench U, Sindelar J, Busch SH, Buerhaus PI.

JAMA. 2015 Mar 24-31;313 (12) :1265-7. PMID: 25803350

2.

An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation.

Chaloupka FJ, Warner KE, Acemoğlu D, Gruber J, Laux F, Max W, Newhouse J, Schelling T, Sindelar J.

Tob Control. 2015 Mar;24 (2) :112-9. Epub 2014 Dec 30. PMID: 25550419

3.

Financial versus health motivation to quit smoking: a randomized field study.

Sindelar JL, O'Malley SS.

Prev Med. 2014 Feb;59 :1-4. Epub 2013 Oct 16. PMID: 24139975

4.

Is research in substance abuse undervalued?

Sindelar JL, Strombotne KL.

Addiction. 2014 Jan;109 (1) :3-4. Epub 2013 Oct 9. PMID: 24118168

5.

Rewarding healthy food choices in SNAP: behavioral economic applications.

Richards MR, Sindelar JL.

Milbank Q. 2013 Jun;91 (2) :395-412. PMID: 23758515

6.

Smoke-free policies in drinking venues predict transitions in alcohol use disorders in a longitudinal U.S. sample.

Young-Wolff KC, Hyland AJ, Desai R, Sindelar J, Pilver CE, McKee SA.

Drug Alcohol Depend. 2013 Mar 1;128 (3) :214-21. Epub 2012 Sep 20. PMID: 22999418

7.

Understanding heterogeneity in price elasticities in the demand for alcohol for older individuals.

Ayyagari P, Deb P, Fletcher J, Gallo W, Sindelar JL.

Health Econ. 2013 Jan;22 (1) :89-105. Epub 2011 Dec 12. PMID: 22162113

8.

Optimizing financial incentives to improve health among military personnel: differences by pay grade and across branches.

Sindelar JL, Torsiello N.

Prev Med. 2012 Nov;55 Suppl :S116-7. Epub 2012 Jun 5. PMID: 22673693

9.

The Effects of Family Stressors on Substance Use Initiation in Adolescence.

Fletcher JM, Sindelar JL.

Rev Econ Househ. 2012 Mar;10 (1) :99-114. PMID: 24058324

10.

Cumulative effects of job characteristics on health.

Fletcher JM, Sindelar JL, Yamaguchi S.

Health Econ. 2011 May;20 (5) :553-70. PMID: 21433217

11.

The effect of job loss on overweight and drinking.

Deb P, Gallo WT, Ayyagari P, Fletcher JM, Sindelar JL.

J Health Econ. 2011 Mar;30 (2) :317-27. Epub 2011 Jan 14. PMID: 21288586

12.

Differential changes in body mass index after retirement by occupation: hierarchical models.

Gueorguieva R, Sindelar JL, Wu R, Gallo WT.

Int J Public Health. 2011 Feb;56 (1) :111-6. Epub 2010 Jul 13. PMID: 20625792

13.

The morning after: alcohol misuse and employment problems.

French MT, Maclean JC, Sindelar JL, Fang H.

Appl Econ. 2011;43 (21) :2705-2720. PMID: 22162875

14.

Cost evaluation of evidence-based treatments.

Sindelar JL, Ball SA.

Addict Sci Clin Pract. 2010 Dec;5 (2) :44-51. PMID: 22002453

15.

The Impact of Job Stress on Smoking and Quitting: Evidence from the HRS.

Ayyagari P, Sindelar JL.

B E J Econom Anal Policy. 2010 Jan 1;10 (1) PMID: 21625286

16.

Work expectations, realizations, and depression in older workers.

Falba TA, Sindelar JL, Gallo WT.

J Ment Health Policy Econ. 2009 Dec;12 (4) :175-86. PMID: 20195005

17.

Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients.

Jones ES, Moore BA, Sindelar JL, O'Connor PG, Schottenfeld RS, Fiellin DA.

Drug Alcohol Depend. 2009 Jan 1;99 (1-3) :132-40. Epub 2008 Sep 19. PMID: 18804923

18.

The impact of occupation on self-rated health: cross-sectional and longitudinal evidence from the health and retirement survey.

Gueorguieva R, Sindelar JL, Falba TA, Fletcher JM, Keenan P, Wu R, Gallo WT.

J Gerontol B Psychol Sci Soc Sci. 2009 Jan;64 (1) :118-24. Epub 2009 Feb 4. PMID: 19196689

19.

Willingness to pay for drug rehabilitation: implications for cost recovery.

Bishai D, Sindelar J, Ricketts EP, Huettner S, Cornelius L, Lloyd JJ, Havens JR, Latkin CA, Strathdee SA.

J Health Econ. 2008 Jul;27 (4) :959-72. Epub 2007 Dec 5. PMID: 18207264

20.

Paying for performance: the power of incentives over habits.

Sindelar JL.

Health Econ. 2008 Apr;17 (4) :449-51. PMID: 18348117

21.

Spousal concordance in health behavior change.

Falba TA, Sindelar JL.

Health Serv Res. 2008 Feb;43 (1 Pt 1) :96-116. PMID: 18211520

22.

Treatment programs in the National Drug Abuse Treatment Clinical Trials Network.

McCarty D, Fuller B, Kaskutas LA, Wendt WW, Nunes EV, Miller M, Forman R, Magruder KM, Arfken C, Copersino M, Floyd A, Sindelar J, Edmundson E.

Drug Alcohol Depend. 2008 Jan 1;92 (1-3) :200-7. Epub 2007 Sep 17. PMID: 17875368

23.

Clinic variation in the cost-effectiveness of contingency management.

Olmstead TA, Sindelar JL, Petry NM.

Am J Addict. 2007 Nov-Dec;16 (6) :457-60. PMID: 18058410

24.

Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer disease.

Rosenheck RA, Leslie DL, Sindelar JL, Miller EA, Tariot PN, Dagerman KS, Davis SM, Lebowitz BD, Rabins P, Hsiao JK, Lieberman JA, Schneider LS.

Arch Gen Psychiatry. 2007 Nov;64 (11) :1259-68. PMID: 17984395

25.

Equity in private insurance coverage for substance abuse: a perspective on parity.

Barry CL, Sindelar JL.

Health Aff (Millwood). 2007 Nov-Dec;26 (6) :w706-16. Epub 2007 Oct 23. PMID: 17956926

26.

The cost-effectiveness of four treatments for marijuana dependence.

Olmstead TA, Sindelar JL, Easton CJ, Carroll KM.

Addiction. 2007 Sep;102 (9) :1443-53. Epub 2007 Jul 23. PMID: 17645430

27.

Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs.

Sindelar JL, Olmstead TA, Peirce JM.

Addiction. 2007 Sep;102 (9) :1463-71. Epub 2007 Jul 23. PMID: 17645428

28.

Smoking status as a clinical indicator for alcohol misuse in US adults.

McKee SA, Falba T, O'Malley SS, Sindelar J, O'Connor PG.

Arch Intern Med. 2007 Apr 9;167 (7) :716-21. PMID: 17420431

29.

Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs.

Olmstead TA, Sindelar JL, Petry NM.

Drug Alcohol Depend. 2007 Mar 16;87 (2-3) :175-82. Epub 2006 Sep 12. PMID: 16971054

30.

Why are recovering substance abuse counselors paid less?

Olmstead TA, Johnson JA, Roman PM, Sindelar JL.

Subst Abus. 2007 Mar;28 (1) :31-44. PMID: 19263560

31.

What do we get for our money? Cost-effectiveness of adding contingency management.

Sindelar J, Elbel B, Petry NM.

Addiction. 2007 Feb;102 (2) :309-16. PMID: 17222286

32.

Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs.

McCarty D, Fuller BE, Arfken C, Miller M, Nunes EV, Edmundson E, Copersino M, Floyd A, Forman R, Laws R, Magruder KM, Oyama M, Prather K, Sindelar J, Wendt WW.

Psychiatr Serv. 2007 Feb;58 (2) :181-90. PMID: 17287373

33.

Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia.

Rosenheck RA, Leslie DL, Sindelar J, Miller EA, Lin H, Stroup TS, McEvoy J, Davis SM, Keefe RS, Swartz M, Perkins DO, Hsiao JK, Lieberman J.

Am J Psychiatry. 2006 Dec;163 (12) :2080-9. PMID: 17151158

34.

Effects of a cost-sharing exemption on use of preventive services at one large employer.

Busch SH, Barry CL, Vegso SJ, Sindelar JL, Cullen MR.

Health Aff (Millwood). 2006 Nov-Dec;25 (6) :1529-36. PMID: 17102176

35.

The impact of tobacco expenditure on household consumption patterns in rural China.

Wang H, Sindelar JL, Busch SH.

Soc Sci Med. 2006 Mar;62 (6) :1414-26. Epub 2005 Aug 31. PMID: 16137812

36.

Does the impact of managed care on substance abuse treatment services vary by provider profit status?

Olmstead TA, Sindelar JL.

Health Serv Res. 2005 Dec;40 (6 Pt 1) :1862-82. PMID: 16336553

37.

Poor mental health and smoking: interactive impact on wages.

Jofre-Bonet M, Busch SH, Falba TA, Sindelar JL.

J Ment Health Policy Econ. 2005 Dec;8 (4) :193-203. PMID: 16385145

38.

What are the correlates of substance abuse treatment counselor salaries?

Olmstead TA, Johnson JA, Roman PM, Sindelar JL.

J Subst Abuse Treat. 2005 Oct;29 (3) :181-9. PMID: 16183467

39.

The effect of involuntary job loss on smoking intensity and relapse.

Falba T, Teng HM, Sindelar JL, Gallo WT.

Addiction. 2005 Sep;100 (9) :1330-9. PMID: 16128722

40.

Managed Care's Dual Impact on Outpatient Substance Abuse Treatment: Methadone Maintenance vs. Drug Free.

Sindelar JL, Olmstead TA.

J Drug Issues. 2005 Jul 1;35 (3) :507-528. PMID: 24062595

41.

If smoking increases absences, does quitting reduce them?

Sindelar JL, Duchovny N, Falba TA, Busch SH.

Tob Control. 2005 Apr;14 (2) :99-105. PMID: 15791019

42.

The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment.

Dodge R, Sindelar J, Sinha R.

J Subst Abuse Treat. 2005 Mar;28 (2) :189-96. PMID: 15780549

43.

Securitization of tobacco settlement payments to reduce states' conflict of interest.

Sindelar J, Falba T.

Health Aff (Millwood). 2004 Sep-Oct;23 (5) :188-93. PMID: 15371384

44.

Value to smokers of improved cessation products: evidence from a willingness-to-pay survey.

Busch S, Falba T, Duchovny N, Jofre-Bonet M, O'Malley S, Sindelar J.

Nicotine Tob Res. 2004 Aug;6 (4) :631-9. PMID: 15370159

45.

Are State legislatures responding to public opinion when allocating funds for tobacco control programs?

Snyder A, Falba T, Busch S, Sindelar J.

Health Promot Pract. 2004 Jul;5 (3 Suppl) :35S-45S. PMID: 15231095

46.

Creating an aggregate outcome index: cost-effectiveness analysis of substance abuse treatment.

Jofre-Bonet M, Sindelar JL.

J Behav Health Serv Res. 2004 Jul-Sep;31 (3) :229-41. PMID: 15263863

47.

To what extent are key services offered in treatment programs for special populations?

Olmstead T, Sindelar JL.

J Subst Abuse Treat. 2004 Jul;27 (1) :9-15. PMID: 15223088

48.

The impact of managed care on substance abuse treatment services.

Olmstead T, White WD, Sindelar J.

Health Serv Res. 2004 Apr;39 (2) :319-43. PMID: 15032957

49.

Cost effectiveness of disulfiram: treating cocaine use in methadone-maintained patients.

Jofre-Bonet M, Sindelar JL, Petrakis IL, Nich C, Frankforter T, Rounsaville BJ, Carroll KM.

J Subst Abuse Treat. 2004 Apr;26 (3) :225-32. PMID: 15063917

50.

Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes.

Sindelar JL, Jofre-Bonet M, French MT, McLellan AT.

Drug Alcohol Depend. 2004 Jan 7;73 (1) :41-50. PMID: 14687958

51.

Reduction of quantity smoked predicts future cessation among older smokers.

Falba T, Jofre-Bonet M, Busch S, Duchovny N, Sindelar J.

Addiction. 2004 Jan;99 (1) :93-102. PMID: 14678067

52.

Burning a hole in the budget: tobacco spending and its crowd-out of other goods.

Busch SH, Jofre-Bonet M, Falba TA, Sindelar JL.

Appl Health Econ Health Policy. 2004;3 (4) :263-72. PMID: 15901200

53.

Economic costs of influenza-related work absenteeism.

Akazawa M, Sindelar JL, Paltiel AD.

Value Health. 2003 Mar-Apr;6 (2) :107-15. PMID: 12641861

54.

Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI.

French MT, Salomé HJ, Sindelar JL, McLellan AT.

Health Serv Res. 2002 Apr;37 (2) :433-55. PMID: 12036002

55.

Drug Treatment as a Crime Fighting Tool.

Jofre-Bonet M, Sindelar JL.

J Ment Health Policy Econ. 2001 Dec 1;4 (4) :175-178. PMID: 12119427

56.

Opioid maintenance: the politics matter.

Sindelar JL.

Addiction. 2001 Oct;96 (10) :1517-8. PMID: 11599514

57.

Innovations in treatment for drug abuse: solutions to a public health problem.

Sindelar JL, Fiellin DA.

Annu Rev Public Health. 2001;22 :249-72. PMID: 11274521

58.

Can the Treatment Services Review be used to estimate the costs of addiction and ancillary services?

French MT, Roebuck MC, McLellan AT, Sindelar JL.

J Subst Abuse. 2000;12 (4) :341-61. PMID: 11452838

59.

Linking health-related quality-of-life indicators to large national data sets.

Rizzo JA, Sindelar JL.

Pharmacoeconomics. 1999 Nov;16 (5 Pt 1) :473-82. PMID: 10662394

60.

Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.

Avants SK, Margolin A, Sindelar JL, Rounsaville BJ, Schottenfeld R, Stine S, Cooney NL, Rosenheck RA, Li SH, Kosten TR.

Am J Psychiatry. 1999 Jan;156 (1) :27-33. PMID: 9892294

61.

Linking the health utilities index to National Medical Expenditure Survey data.

Rizzo JA, Pashko S, Friedkin R, Mullahy J, Sindelar JL.

Pharmacoeconomics. 1998 May;13 (5 Pt 1) :531-41. PMID: 10180752

62.

Drinking, problem drinking, and productivity.

Mullahy J, Sindelar JL.

Recent Dev Alcohol. 1998;14 :347-59. PMID: 9751953

63.

Women and work: tipplers and teetotalers.

Mullahy J, Sindelar JL.

Health Econ. 1997 Sep-Oct;6 (5) :533-7. PMID: 9353657

64.

Employment, unemployment, and problem drinking.

Mullahy J, Sindelar J.

J Health Econ. 1996 Aug;15 (4) :409-34. PMID: 10164037

65.

Disability compensation and work among veterans with psychiatric and nonpsychiatric impairments.

Rosenheck R, Frisman L, Sindelar J.

Psychiatr Serv. 1995 Apr;46 (4) :359-65. PMID: 7788457

66.

Alcoholism and income: the role of indirect effects.

Mullahy J, Sindelar JL.

Milbank Q. 1994;72 (2) :359-75. PMID: 8007903

67.

The emergent problem of ambulance misuse.

Brown E, Sindelar J.

Ann Emerg Med. 1993 Apr;22 (4) :646-50. PMID: 8457089

68.

Can we regulate the quality of care?: the case of dialysis in Connecticut.

Brown E, Smith JD, Sindelar J.

Am J Kidney Dis. 1992 Jun;19 (6) :609-13. PMID: 1595713

69.

Economic cost of illicit drug studies: critique and research agenda.

Sindelar JL.

NIDA Res Monogr. 1991;113 :33-45. PMID: 1762641

70.

Treatment adherence and risk of death after a myocardial infarction.

Horwitz RI, Viscoli CM, Berkman L, Donaldson RM, Horwitz SM, Murray CJ, Ransohoff DF, Sindelar J.

Lancet. 1990 Sep 1;336 (8714) :542-5. PMID: 1975045

71.

The forgiveness of coinsurance. Charity or cheating?

Lachs MS, Sindelar JL, Horwitz RI.

N Engl J Med. 1990 May 31;322 (22) :1599-602. PMID: 2336091

72.

Life-cycle effects of alcoholism on education, earnings, and occupation.

Mullahy J, Sindelar J.

Inquiry. 1989 Summer;26 (2) :272-82. PMID: 2526095

73.

Yield curve strategy increases capital gains on investments.

Sindelar JL.

Healthc Financ Manage. 1989 May;43 (5) :121-3. PMID: 10292504

74.

An assessment of the anticompetitive effects of preferred provider organizations.

Greaney TL, Sindelar JL.

Inquiry. 1987 Winter;24 (4) :384-91. PMID: 2961699

75.

The effect of injecting price competition into the hospital market: the case of preferred provider organizations.

Dranove D, Satterthwaite M, Sindelar J.

Inquiry. 1986 Winter;23 (4) :419-31. PMID: 2947862

76.

Behaviorally caused loss of health and the use of medical care.

Sindelar JL.

Econ Inq. 1982 Jul;20 (3) :458-71. PMID: 10256482

77.

Differential use of medical care by sex.

Sindelar JL.

J Polit Econ. 1982;90 (5) :1003-19. PMID: 11632327

78.

The value of time and the use of medical care.

Sindelar JL.

Socioecon Issues Health. 1981; :51-75. PMID: 10259679